×
0.0252631578947369 0.0252631578947369 0.0252631578947369 0.0252631578947369 0.0110526315789474 0.0210526315789475 0.0465789473684211 0.0594736842105264
Stockreport

Kiniksa to Present Late-Breaking KPL-716 Clinical Data at the 27th European Academy of Dermatology and Venereology

KINIKSA PHARMACEUTICALS LTD CL A COMMON (KNSA)  More Company Research Source: GlobeNewswire
PDF HAMILTON, Bermuda, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients with significant unmet medical need, today announced that it will present clinical data for KPL-716, an investigational fully-human monoclonal antibody that targets oncostatin M receptor beta (OSMRß), at the 27th European Academy of Dermatology and Venereology (EADV) Congress in Paris. During the Late-Breaking News Session on Saturday, September 15th, 2018, Dr. Zamaneh Mikhak of Kiniksa will deliver an oral presentation of the company’s placebo-controlled, double-blind, single-ascending-dose, Phase 1a/1b clinical trial of KPL-716. This clinical trial evaluated the safety, tolerability, pharmacokinetics and immunogenicity of intravenous or subcutaneous KPL-716 in healthy volunteers and subjects with moderate-to-severe atopic dermat [Read more]

IMPACT SNAPSHOT EVENT TIME: KNSA
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
KNSA alerts

from News Quantified
Opt-in for
KNSA alerts

from News Quantified